MX2012005618A - Derivados de lactona macrociclica para el tratamiento del cancer. - Google Patents
Derivados de lactona macrociclica para el tratamiento del cancer.Info
- Publication number
- MX2012005618A MX2012005618A MX2012005618A MX2012005618A MX2012005618A MX 2012005618 A MX2012005618 A MX 2012005618A MX 2012005618 A MX2012005618 A MX 2012005618A MX 2012005618 A MX2012005618 A MX 2012005618A MX 2012005618 A MX2012005618 A MX 2012005618A
- Authority
- MX
- Mexico
- Prior art keywords
- sub
- cancer
- treatment
- formula
- pharmaceutically acceptable
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 3
- 150000002596 lactones Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26185609P | 2009-11-17 | 2009-11-17 | |
| PCT/IB2010/055161 WO2011061666A1 (en) | 2009-11-17 | 2010-11-15 | Macrocyclic lactone derivatives for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012005618A true MX2012005618A (es) | 2012-08-15 |
Family
ID=43566625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012005618A MX2012005618A (es) | 2009-11-17 | 2010-11-15 | Derivados de lactona macrociclica para el tratamiento del cancer. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8637683B2 (enExample) |
| EP (1) | EP2501689A1 (enExample) |
| JP (1) | JP2013510899A (enExample) |
| KR (1) | KR20120092677A (enExample) |
| CN (1) | CN102666523A (enExample) |
| AU (1) | AU2010320557A1 (enExample) |
| CA (1) | CA2792198A1 (enExample) |
| IL (1) | IL219807A0 (enExample) |
| MX (1) | MX2012005618A (enExample) |
| NZ (1) | NZ600660A (enExample) |
| RU (1) | RU2012124817A (enExample) |
| WO (1) | WO2011061666A1 (enExample) |
| ZA (1) | ZA201204488B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011061667A1 (en) * | 2009-11-17 | 2011-05-26 | Piramal Life Sciences Limited | Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders |
| WO2014118740A1 (en) * | 2013-02-04 | 2014-08-07 | Piramal Enterprises Limited | Macrocyclic lactone derivatives and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9504617D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Ab | Active compounds II |
| WO2011061667A1 (en) * | 2009-11-17 | 2011-05-26 | Piramal Life Sciences Limited | Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders |
-
2010
- 2010-11-15 KR KR1020127015787A patent/KR20120092677A/ko not_active Withdrawn
- 2010-11-15 JP JP2012539450A patent/JP2013510899A/ja active Pending
- 2010-11-15 CA CA2792198A patent/CA2792198A1/en not_active Abandoned
- 2010-11-15 WO PCT/IB2010/055161 patent/WO2011061666A1/en not_active Ceased
- 2010-11-15 EP EP10798188A patent/EP2501689A1/en not_active Withdrawn
- 2010-11-15 CN CN201080057594XA patent/CN102666523A/zh active Pending
- 2010-11-15 RU RU2012124817/04A patent/RU2012124817A/ru not_active Application Discontinuation
- 2010-11-15 US US13/510,458 patent/US8637683B2/en not_active Expired - Fee Related
- 2010-11-15 AU AU2010320557A patent/AU2010320557A1/en not_active Abandoned
- 2010-11-15 MX MX2012005618A patent/MX2012005618A/es not_active Application Discontinuation
- 2010-11-15 NZ NZ600660A patent/NZ600660A/en not_active IP Right Cessation
-
2012
- 2012-05-15 IL IL219807A patent/IL219807A0/en unknown
- 2012-06-18 ZA ZA2012/04488A patent/ZA201204488B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8637683B2 (en) | 2014-01-28 |
| ZA201204488B (en) | 2014-08-27 |
| EP2501689A1 (en) | 2012-09-26 |
| RU2012124817A (ru) | 2013-12-27 |
| US20120245183A1 (en) | 2012-09-27 |
| IL219807A0 (en) | 2012-07-31 |
| AU2010320557A1 (en) | 2012-07-05 |
| KR20120092677A (ko) | 2012-08-21 |
| CA2792198A1 (en) | 2011-05-26 |
| NZ600660A (en) | 2014-02-28 |
| JP2013510899A (ja) | 2013-03-28 |
| CN102666523A (zh) | 2012-09-12 |
| WO2011061666A1 (en) | 2011-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200833675A (en) | Nicotinamide derivatives | |
| GEP20146146B (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 | |
| MX2010007375A (es) | Nuevos derivados de lupano. | |
| WO2008008539A3 (en) | Fused heterocyclic derivatives useful as inhibitors of the hepatocyte growth factor receptor | |
| MY155653A (en) | Triazine compounds as p13 kinase and mtor inhibitors | |
| MX2009012168A (es) | Derivados de pirrolopiridina y su uso como inhibidores de la enzima que escinde la proteina precursora de amiloide por el sitio beta. | |
| NO20076196L (no) | Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander | |
| NO20072371L (no) | Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister | |
| MX2010001189A (es) | Derivados de naftiridina como modulares del canal de potasio. | |
| MX2010007683A (es) | Derivados heterociclicos fusionados y metodos de uso como inhibidores de c-met. | |
| NO20076197L (no) | Nye 2-azetidinonderivater anvendbare i behandling av hyperlipidemiske tilstander | |
| WO2008012635A3 (en) | Amine derivatives useful as anticancer agents | |
| TW200728307A (en) | Novel spirochromanone derivatives | |
| MX358961B (es) | Compuestos de tetraciclina sustituidos con fluor en c7. | |
| UA94606C2 (ru) | Производные тиоксантина, композиция, которая их содержит, и их применение в терапии | |
| EA200870423A1 (ru) | Производные триазолпиразинов, применимые в качестве противораковых агентов | |
| MX2010007374A (es) | Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos. | |
| IL197262A0 (en) | Anti cancer use of caffeic acid and its derivatives | |
| CA2817362C (en) | Lipoyl compounds and their use for treating ischemic injury | |
| WO2010129057A8 (en) | Tetracycline compounds | |
| WO2013177534A3 (en) | New salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof | |
| WO2011025982A3 (en) | Tetracycline compounds | |
| WO2010132670A3 (en) | Pentacycline compounds | |
| MX2011012068A (es) | Nucleosidos 2'-fluoro arabino y su utilizaicon. | |
| MX2012005618A (es) | Derivados de lactona macrociclica para el tratamiento del cancer. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: PIRAMAL ENTERPRISES LIMITED.* |
|
| HC | Change of company name or juridical status |
Owner name: PIRAMAL ENTERPRISES LIMITED.* |
|
| FA | Abandonment or withdrawal |